MicroRNA-24 antagonism prevents renal ischemia reperfusion injury

Johan M Lorenzen, Tamas Kaucsar, Celina Schauerte, Roland Schmitt, Song Rong, Anika Hübner, Kristian Scherf, Jan Fiedler, Filippo Martino, Regalla Kumarswamy, Malte Kölling, Inga Sörensen, Hebke Hinz, Joerg Heineke, Eva van Rooij, Hermann Haller, Thomas Thum

Research output: Contribution to journal/periodicalArticleScientificpeer-review

Abstract

Ischemia-reperfusion (I/R) injury of the kidney is a major cause of AKI. MicroRNAs (miRs) are powerful regulators of various diseases. We investigated the role of apoptosis-associated miR-24 in renal I/R injury. miR-24 was upregulated in the kidney after I/R injury of mice and in patients after kidney transplantation. Cell-sorting experiments revealed a specific miR-24 enrichment in renal endothelial and tubular epithelial cells after I/R induction. In vitro, anoxia/hypoxia induced an enrichment of miR-24 in endothelial and tubular epithelial cells. Transient overexpression of miR-24 alone induced apoptosis and altered functional parameters in these cells, whereas silencing of miR-24 ameliorated apoptotic responses and rescued functional parameters in hypoxic conditions. miR-24 effects were mediated through regulation of H2A histone family, member X, and heme oxygenase 1, which were experimentally validated as direct miR-24 targets through luciferase reporter assays. In vitro, adenoviral overexpression of miR-24 targets lacking miR-24 binding sites along with miR-24 precursors rescued various functional parameters in endothelial and tubular epithelial cells. In vivo, silencing of miR-24 in mice before I/R injury resulted in a significant improvement in survival and kidney function, a reduction of apoptosis, improved histologic tubular epithelial injury, and less infiltration of inflammatory cells. miR-24 also regulated heme oxygenase 1 and H2A histone family, member X, in vivo. Overall, these results indicate miR-24 promotes renal ischemic injury by stimulating apoptosis in endothelial and tubular epithelial cell. Therefore, miR-24 inhibition may be a promising future therapeutic option in the treatment of patients with ischemic AKI.

Original languageEnglish
Pages (from-to)2717-29
Number of pages13
JournalJournal of the American Society of Nephrology
Volume25
Issue number12
DOIs
Publication statusPublished - Dec 2014

Fingerprint

Dive into the research topics of 'MicroRNA-24 antagonism prevents renal ischemia reperfusion injury'. Together they form a unique fingerprint.

Cite this